ライフサイエンスコーパス: death rate

1 below both ECG thresholds (13.9% versus 5.5% death rate).

2 a were independently associated to increased death rate.

3 progeny with low viability and high cellular death rate.

4 uce both its transmission and the associated death rate.

5 lin production and rise in blood glucose and death rate.

6 nced by a precisely regulated and equivalent death rate.

7 planation for a modest increase in premature death rate.

8 effect by increasing the infected hepatocyte death rate.

9 ature corresponded to an increase of 2.5% in death rate.

10 gression of lung injury and reduce influenza death rates.

11 n severe human respiratory disease with high death rates.

12 e annual percentage changes in incidence and death rates.

13 , in particular by differences in progenitor death rates.

14 55 years), CGS was lowered by higher patient death rates.

15 ng cessation at any age dramatically reduced death rates.

16 tribute to regional variability in wait-list death rates.

17 tation rates are much smaller than birth and death rates.

18 eatinine decline were associated with higher death rates.

19 ted with higher charges, length of stay, and death rates.

20 and division rates to a greater extent than death rates.

21 d and unpredictable nutrient supply and high death rates.

22 ey data for occupation and industry-specific death rates.

23 critical congenital heart disease and infant death rates.

24 rall CVD rates and racial disparities in CVD death rates.

25 a significant impact on human cause-specific death rates.

26 ted with hospital-level 30-day postoperative death rates.

27 city is also related to human cause-specific death rates.

28 d infections also had a significantly higher death rate (0.04; CI, 0.01-0.08).

29 ith a low rate of incident death (annualized death rate: 0.28%).

30 major adverse cardiac event rate was 19.9% (death rate: 1.2%; recurrent MI: 16.8%; stroke/transient

31 Exposed infants had a lower hospital death rate (14.2% vs 18.5% ; OR, 0.73 [95% CI, 0.54 to 0

32 We examined female age-specific lung cancer death rates (1973 through 2007) by year of death and bir

33 by a significantly higher induction-related death rate (2.5% vs 0.9%, P = .00013), resulting in 5-ye

34 ate compared to the province with the lowest death rate, 2.2 times higher in black Africans compared

35 52%; P = .14) as a result of a higher early death rate (26% vs 14%; P = .06).

36 Marked variation among DSAs was evident in death rate (3.3-fold), transplant rate (20-fold), and me

37 Consequently, a higher neonatal death rate (57.1%) in hUGT1/Tlr2(-/-) mice was observed

38 Total CR was 25%, day 30 death rate 7%.

39 The remarkable reduction in death rates achieved with these therapies has resulted i

40 .79.) Analysis revealed a broad range in the death rate across OPOs: trauma deaths: 44-118 PMP; death

41 Combined BPD or death rates across 116 NICUs varied from 17.7% to 73.4%

42 e observed striking differences in birth and death rates across miRNA classes defined by biogenesis p

43 There was evidence of heterogeneity of death rates across studies (chi(2) = 22.6; df = 8; P = 0

44 ur health outcomes were investigated: annual death rate, Activities of Daily Living (ADL), physical p

45 The crude annual death rate after a spontaneous bleed (9.5%) or MI (7.6%)

46 s in the hospital-level 30-day postoperative death rate after inpatient surgery ranging from 14% to 2

47 The cell death rate after MNFH was dramatically decreased by incr

48 ined the model parameters (such as birth and death rates, age-specific incidence rates, and age-speci

49 ly worse than the EU15+ for age-standardised death rates, age-standardised YLL rates, and life expect

50 rborne viruses that lead to high disease and death rates all over the world.

51 The male radiologists had lower death rates (all causes) compared with the psychiatrists

52 sector, because lung cancer has the highest death rate among all cancer types, and it brings a high

53 The mean liver-related death rate among the general population during the study

54 We examined 30-year cause-specific death rates among 21 693 MI patients <50 years versus 21

55 from 13 sub-Saharan African studies tracking death rates among adult patients who were lost to follow

56 e southern states (eg, Alabama), lung cancer death rates among women born in the 1960s were approxima

57 ed that declines in age-specific lung cancer death rates among women in the United States abruptly sl

58 ause mortality, as well as AIDS and non-AIDS death rates, among patients started on antiretroviral th

59 TD increases the death rate and can be minimized by limiting use of typic

60 atient's fibroblasts exhibited elevated cell death rate and higher reactive oxygen species (ROS) prod

61 ic nanofluid hyperthermia (MNFH) on the cell death rate and the heat shock proteins 72 (HSP72) induct

62 It was clearly observed that the cell death rate and the HSP72 induction rate had a strong dep

63 eteriorating environments, one with a rising death rate and the other one with decreasing nutrient av

64 However, hypothermia resulted in lower death rates and did not increase rates of severe disabil

65 the smallest error to forecast age-specific death rates and life expectancy to 2030 for 375 of Engla

66 uctural standards, they often result in high death rates and mass casualties with many traumatic inju

67 County-level death rates and national life tables for each year were

68 All death rates and numbers have been estimated with 95% unc

69 nd annual percent change in age-standardized death rates and years of potential life lost before age

70 would be seen in the 2030 population at 2010 death rates), and improve health care at all ages".

71 genesis (the cell-cycle rate, the progenitor death rate, and the "quit rate," i.e., the ratio of term

72 rs that determine which policy minimizes the death rate, and thus serves as a guide for the design of

73 -49 years that would be seen in 2030 at 2010 death rates, and about 17 million of the 41 million such

74 dimycocerosate (PDIM) exhibited significant death rates, and consequently, total bacterial numbers w

75 diet, risk characteristics, disease-specific death rates, and their ecologic and individual associati

76 Death rates are higher in HIV-infected versus uninfected

77 Cardiovascular disease (CVD) death rates are much higher in blacks than whites in the

78 Birth and death rates are not fixed, and no assumptions are made r

79 ly lower hospital-level 30-day postoperative death rates (aRR 0.83, 95% CI 0.70-0.97, P = 0.02).

80 and cerebrovascular disease age-standardized death rates (as per International Classification of Dise

81 ially in women, seems to modify the elevated death rate associated with high milk consumption.

82 estinal events; there was no increase in the death rate at days 60 + 90.

83 at 6 months, lower overall/disease-specific death rates at 12 months, and higher median survival.

84 Severe bronchopulmonary dysplasia/death rates at 36 weeks' postmenstrual age were similar

85 tancy at birth and HALE increased, all-cause death rates at all ages decreased, and age-specific rate

86 Age-standardized CVD death rates attributable to established risk factors plu

87 in cardiac revascularization therapy reduced death rates because of myocardial infarction but steadil

88 no difference in noncardiovascular or cancer death rates between groups.

89 ith hepatitis C virus infection and compared death rates between waiting list and kidney transplantat

90 y time during MNFH affects not only the cell death rate but also HSP72 induction rate.

91 treatment can change cancer incidence and/or death rates, but it will require a concerted effort by t

92 oson (LTR-RT) type of TE, we estimated their death rates by counting solo-LTRs and truncated elements

93 f the effect of smoking on mortality yielded death rates by smoking status.

94 Nevertheless, viral replication and cell death rates caused by two TLR3-dependent viruses (HSV-1

95 We incorporated a cell death rate (CDR) function into a previous dynamical PSA

96 d 2010, the US rank for the age-standardized death rate changed from 18th to 27th, for the age-standa

97 e-specific, sex-specific, and cause-specific death rates combine to drive a broad shift from communic

98 epair in ESRD patients had complications and death rates comparable with non-ESRD patients.

99 imes higher in the province with the highest death rate compared to the province with the lowest deat

100 ack patients undergoing dialysis had a lower death rate compared with white patients (232,361 deaths

101 Il6-deficient mice had a lower death rate compared with wild-type mice with AP, while m

102 The co-cases showed increased death rates compared with the co-controls (hazard ratio,

103 of patients given intensive treatment, early death rate, complete remission rate, use of allogeneic t

104 Death rate correlated with organ availability was assess

105 Congenital heart defect (CHD)-related death rates correlated with defect severity.

106 Trauma deaths and death rates deceased in individuals younger than 25 year

107 Age-specific lung cancer death rates declined continuously in white women in Cali

108 Although overall MVA death rates declined during this period, socioeconomic d

109 Although overall age-standardised death rates decreased by 29.0% (28.7 to 29.3) from 1990

110 doses of corticosteroids were used, whereas death rates did not differ between the therapeutic regim

111 4-5.27), more than 0.5 times higher than the death rate during the 26-mo period preceding the war, re

112 Death rate during the study period was 16/843 (2%), sign

113 This ecologic study notes that fetal death rates (FDR) during the Washington DC drinking wate

114 The accident death rate fell sharply among currently deployed soldier

115 Nationally, age-standardised death rates fell 13.3% (11.9-14.6%) since 1990, but stat

116 sease in particular), but for most diseases, death rates fell in the past two decades; including majo

117 resource-poor settings, and complication and death rates following surgery are probably substantial b

118 effects were used to compare the lung cancer death rate for a given birth cohort to a referent birth

119 time segment detected by joinpoint analysis, death rate for COPD in men began to decrease and the dec

120 The death rate for COPD increased during this period.

121 olute number of patients and the in-hospital death rate for crucial subcategories such as medical ind

122 verted in each state by applying the average death rate for the five states with the lowest rates amo

123 During this period, death rates for cancer and heart disease decreased.

124 Intracranial bleeds and death rates for dabigatran 150 and 110 mg were lower com

125 Using crude death rates for each country and the calculated proporti

126 Mortality was compared with national death rates for England and Wales, and associations with

127 s and computed age-adjusted and age-specific death rates for the top-named drugs and for prescription

128 Cumulative melanoma-related death rates for thickness groups of patients with thin m

129 a result of earlier and larger reductions in death rates for whites.

130 s could reduce black-white difference in CVD death rate from 1659 to 1244 per 100 000 in men and from

131 a decrease in the pediatric CHD in-hospital death rate from 5.1 to 2.3 per 100,000 between 1983 and

132 The death rate from HCC was twice that of DCC.

133 tes reduce the recently reported increase in death rate from heart disease.

134 The death rate from hepatocellular carcinoma (HCC) is increa

135 The overall death rate from lung cancer is higher in black patients

136 in education-related inequalities in US MVA death rates from 1995 to 2010.

137 GI age-specific and cause-specific trends in death rates from 2000 to 2014 were projected to 2030 and

138 ites was largely accounted for by increasing death rates from drug and alcohol poisonings, suicide, a

139 kers (before 1940) there were also increased death rates from melanoma (RR = 8.75; 95% CI: 1.89, 40.5

140 rwise have been screened resulted in reduced death rates from prostate cancer, but it is uncertain wh

141 Age standardised death rates from some key disorders rose (HIV/AIDS, Alzh

142 We use more than six decades of death rates from US hurricanes to show that feminine-nam

143 Vibrio vulnificus has the highest death rate (>35%) and per-case economic burden ($3.3 mil

144 The death rate has decreased, the number of bed days has inc

145 ence of IL-15 on murine NK cell division and death rates has not been quantitatively studied.

146 Cervical cancer death rates have been decreasing but the disease still k

147 n are declining, but it is not known whether death rates have declined similarly for older and younge

148 05% versus non-HCC 40.60%), and waiting list death rates (HCC 4.49% versus non-HCC 24.63%).

149 [HR], 0.55; 95% CI, 0.48-0.64), an increased death rate (HR, 1.52; 95% CI, 1.16-2.00), and an overall

150 A high cardiac death rate impacts results of KTA and calls for stringen

151 a statistically significant 39% reduction in death rate in favor of the trastuzumab-containing arm (P

152 ected cells showed significant increasing of death rate in hypoxic hepatoma cells compared to control

153 m March 1, 2003, to June 30, 2011, the crude death rate in Iraq was 4.55 per 1,000 person-years (95%

154 Cancer death rate in SOTRs was increased compared with that exp

155 hest adolescent childbirth rate and maternal death rate in sub-Saharan Africa.

156 <4 weeks of aortic constriction, whereas the death rate in the ACi plus CGP group was not different f

157 The 30-day death rate in the STEMI cohort was 31.2% and 8.5% in the

158 s being considered by some to reduce cardiac death rates in athletes, but the death rates in defined

159 uce cardiac death rates in athletes, but the death rates in defined groups screened by the current U.

160 lt mortality by district, notably the higher death rates in eastern India, requires further aetiologi

161 INTERPRETATION: Suicide death rates in India are among the highest in the world.

162 and 2013, despite a decrease in age-specific death rates in most regions.

163 CHD death rates in older groups are now falling steeply.

164 Critical congenital heart disease death rates in states with mandatory screening policies

165 t temperatures are associated with increased death rates in the short term.

166 Recent data demonstrated that breast cancer death rates in the US population are declining, but it i

167 least education had significantly higher CRC death rates in virtually all states for each racial/ethn

168 , which was probably entirely due to the low death rates in young background population.

169 ve 2; outside Milwaukee, hospitalization and death rates increased 10- and 8-fold, respectively.

170 All-cause age-standardised death rates increased rapidly since 1997, peaked in 2006

171 Mortality assessed by drug overdose death rates involving prescription opioids increased fro

172 ing policies has been associated with infant death rates is unknown.

173 logical transition models in which decreased death rates occur across all ages.

174 -day mortality was 16.5% with a drug-related death rate of 0.4%.

175 igh with disfiguring treatment options and a death rate of 1 per hour in the United States.

176 nts increased to 12.9% per year, including a death rate of 10% per year.

177 EF >35%, below-median %PIZ carried an annual death rate of 2.8% versus 12% in patients with above-med

178 elated deaths, with an age- and sex-adjusted death rate of 27.0/100,000 persons (95% confidence inter

179 sease study estimate of age-standardized CVD death rate of 272 per 100 000 population in India is hig

180 se mice, consequently leading to a premature death rate of 40% within 2 weeks of treatment, despite d

181 s, leading to kidney failure and a premature death rate of 67% by 9 weeks of age.

182 Respondents in the lowest third of PA had a death rate of 7.3%, compared with 4.6% in the medium-PA

183 In this Gambian population, the increased death rate of individuals born in nutritionally poor sea

184 e of second phase decay is determined by the death rate of infected cells multiplied by the maximum e

185 at reduce viral infectivity and increase the death rate of infected cells promote coexistence, which

186 ilability contribute to variation in overall death rate of liver transplant patients, shape the clini

187 y human neutrophils and a corresponding high death rate of mice after injection of these cells.

188 cytosis by human neutrophils, and a very low death rate of mice infected with AP53/covR(+)S(+).

189 The incidence and death rate of pancreatic ductal adenocarcinoma (PDAC) ha

190 The 5-year cumulative melanoma-related death rate of patients with ultrathin melanomas was high

191 The age-standardised death rate of those with a potentially surgical conditio

192 MR study corresponded to low annual MACE and death rates of 0.8% and 0.3%, respectively.

193 940-0.962), with a ratio of trends in annual death rates of 0.981 (95% CI, 0.968-0.993).

194 d produced lower values for the division and death rates of bacteria: these improved the goodness-of-

195 ds to an estimate for the ratio of birth and death rates of cancer cells during the early stages of c

196 have disproportionately higher incidence and death rates of colorectal cancer among all ethnic groups

197 of the regional leaders, then cause-specific death rates of fewer than three deaths per 1000 livebirt

198 hly variable, depending mostly on growth and death rates of the individual CLL cell clone.

199 oided if everyone had experienced the lowest death rates of the most educated whites.

200 redraw their original graphs of age-specific death rates of tuberculosis organized either by year of

201 For the incidence (hospitalisation or death) rates of specific diseases, RRs were as follows:

202 a was correlated with change in age-specific death rates only among upper-middle income countries, an

203 crashes have examined only population-based death rates or have been restricted to hospitalized pati

204 Crude death rates over a mean follow-up of 1.5 years (SD 1.1)

205 = 0.94; 95% CI: 0.90, 0.97), similar cancer death rates overall (RR = 1.00; 95% CI: 0.93, 1.07), but

206 significantly higher cardiac event rate and death rate (p < 0.001 and p = 0.002, respectively).

207 g and baseline characteristics revealed that death rate (P = .02) and survival duration (P = .01) wer

208 C at discharge was associated with a reduced death rate (P<0.01).

209 evalent cases showed significantly different death rates (p=0.021), with an overall average mortality

210 h SJS/TEN is rare and associated with a high death rate, particularly in those with jaundice; however

211 Between 1969 and 2013, the age-standardized death rate per 100,000 decreased from 1278.8 to 729.8 fo

212 (ED100000) and age standardized lung cancer death rate per 100,000 people (ASDR100000) in 2004 were

213 loodstream infections (BSIs) and their crude death rate per 1000 occupied bed days (OBDs).

214 9.1 in 2009-11; we saw similar decreases in death rates per 1000 person-years over the same period f

215 The death rate (per 100 patient-years) among those not hospi

216 y transplant rates range from 18% to 86% and death rates range from 14% to 82% across donation servic

217 fidence interval =0.38-0.97), cardiovascular death (rate ratio =0.38, 95% confidence interval =0.20-0

218 =0.48; 95% confidence interval =0.37-0.61), death (rate ratio =0.60; 95% confidence interval =0.38-0

219 A lower than expected prostate cancer death rate reduced ability to detect a between-group dif

220 long-term health benefits including reduced death rates, reduced cardiovascular disease, and reduced

221 nt, we detected no decreases in AIDS-related death rates (relative rate for 2009-11 vs 1999-2000: 0.9

222 hs in 2020 if 2006 age- and sex-specific CHD death rates remained constant, which would result in app

223 This study shows that the early death rate remains high despite the wide availability of

224 r if it reduces sudden and unexpected infant death rates remains to be studied.

225 The death rate rose markedly with increasing age, and approx

226 oid leukemia and/or myelodysplastic syndrome death rates (RR = 1.62; 95% CI: 1.05, 2.50); these rates

227 In follow-up, these patients had higher death rates (RR = 3.02; P < .001) and recurrence rates (

228 me per person, maternal education, HIV child death rates, secular shifts, and other factors.

229 and cardiovascular disease (0.33 [0.20-0.53) death rates still decreased over time.

230 as associated with a lower treatment-related death rate than a nonpersonalized strategy (median, 1.5%

231 phenotypically unactivated and show a lower death rate than activated T cells, which promotes the su

232 serum creatinine levels increased had lower death rates than did those whose weight increased but wh

233 Males had higher overall 10-year death rates than females, both for total deaths (8.9% ve

234 ntinues to be associated with higher CVD and death rates than the non-diabetic population.

235 In death-controlled growth, it is death rate that increases to slow down expansion.

236 Twin Cities may partly explain the lower CHD death rate there.

237 2013 despite a 39% decrease in age-specific death rates; this increase was driven by a 55% increase

238 is below both the emergency and the baseline death rate thresholds of sub-Saharan Africa.

239 We used age-specific death rates to calculate life expectancy at birth and at

240 bined these relative risks with age-specific death rates to get 20-year absolute risks.

241 The cumulative death rates (total 316) were 12% in A, 14% in E, and 10%

242 ons were highly correlated with waiting list death rates, transplantation rates, and MELD score at re

243 Cell death rates trended higher for Neuro2a cells containing

244 If combined with 2010 UK national death rates, tripled mortality rates among smokers indic

245 his study, we estimate the pooled under-five death rates (U5DR) and assess the effect of drought on c

246 e is sensitive to the way in which birth and death rates vary over time.

247 The 30-day stroke rate was 1.1% and the death rate was 0.7%.

248 The overall death rate was 0.9% (5 of 567), and 2 deaths were relate

249 r patients >70 years old, the sudden cardiac death rate was 1.6 (95% CI, 0.8-3.2) and nonsudden death

250 patients </=70 years old, the sudden cardiac death rate was 1.8 (95% CI, 1.3-2.5) and nonsudden death

251 ascular death rate was 9%, noncardiovascular death rate was 11%, and unknown death rate was 3%.

252 The overall early death rate was 17.3%, and only a modest change in early

253 rate was 1.8 (95% CI, 1.3-2.5) and nonsudden death rate was 2.7 (95% CI, 2.1-3.5) events per 100 pati

254 lete blood count recovery, and if the 30 day death rate was 20% or less.

255 thin 6 months, the cumulative cardiovascular death rate was 22.2%, higher than for patients without a

256 rdiovascular death rate was 11%, and unknown death rate was 3%.

257 The cumulative cardiovascular death rate was 5.2% in patients who had a procedure-rela

258 rate was 1.6 (95% CI, 0.8-3.2) and nonsudden death rate was 5.4 (95% CI, 3.7-7.8) events per 100 pati

259 Cardiovascular death rate was 9%, noncardiovascular death rate was 11%,

260 Death rate was comparable with the UK population (standa

261 months after cancer treatment decision, and death rate was followed.

262 nsplantation (24% and 24%) were similar, the death rate was higher in the early cohort than in the la

263 n an adjusted proportional hazard model, the death rate was increased with long-duration diabetes, pa

264 Overall the perioperative death rate was low even in high-risk patients.

265 R 33.6%, p = 0.92), whereas in Cohort B, the death rate was lower after TAVR (52.0% vs. 69.6% after s

266 Notably, the incremental change of daily death rate was most prominent during the first week sinc

267 overall decreasing trend in age-standardized death rate was observed for all causes combined, heart d

268 No abnormally high death rate was observed in the HHV-6 positive population

269 A significantly reduced death rate was observed in the treated cohort as compare

270 was 17.3%, and only a modest change in early death rate was observed over time.

271 ) with a large disease burden, and the early death rate was only 0.7% (n = 1; 95% CI, 0.1% to 3.7%) c

272 cancer was the highest of any cancer and the death rate was second to that of lung cancer.

273 most all within 4 weeks, and a low induction death rate was seen.

274 The early death rate was significantly higher in patients aged >/=

275 Using experimentally derived division and death rates, we tested each model's assumptions by compa

276 Overall death rates were 1.16 (control) and 1.49 (IAI); overall

277 All-cause age-standardised death rates were 1.7 times higher in the province with t

278 July); for other/unspecified cardiac causes, death rates were 11.7 (95% CI, 8.6-14.8) per 100000 birt

279 % CI, 0.59-1.30; P = .52), whereas all-cause death rates were 137 vs 444 events, respectively (33.7 a

280 Adjusted death rates were 15.3 per 100,000 population (95% confid

281 In relative terms, adjusted death rates were 2.4 (95% CI: 1.7, 3.0) times higher at

282 Corresponding 1-year death rates were 4.4%, 9.1%, 20.2%, and 22.4%.

283 The NICU death rates were 7 of 95 neonates (7%) for the 33.5 degr

284 Changes in intentional firearm death rates were analyzed with negative binomial regress

285 patially smoothed county-level heart disease death rates were calculated for 2-year intervals from 19

286 Age-standardised death rates were calculated with mid-year population est

287 In the model, when forager death rates were chronically elevated, an increasingly y

288 At 5 years, all-cause death rates were higher in those with type 2 myocardial

289 The relative death rates were highest among young patients, which was

290 Death rates were independent of maternal CD (60 deaths p

291 Compared with the general population, cohort death rates were significantly higher than expected (sta

292 In Cohort A, 2-year all-cause death rates were similar (TAVR 35.2% and SAVR 33.6%, p =

293 Death rates were similar between the WPW group versus th

294 Death rates were similar in children born to mothers wit

295 Stillbirth and perinatal death rates were similarly not associated with gestation

296 ardial infarction, stroke, or cardiovascular death, rates were 4.6% in PA and 4.5% in the successful

297 osphate, nitrogen, or sulfate results in low death rates, whereas starvation for amino acids or other

298 pan, control measures targeting the mosquito death rate will be more effective.

299 , by an increased division rate or decreased death rate), with the person as a whole incurring the lo

300 UNPD-projected death rates yield a 25.9% reduction of premature mortali